Whittier Trust »

Lenz Therapeutics shares owned by Whittier Trust

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Whittier Trust from 13F filings

Historical chart of Whittier Trust investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Whittier Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Whittier Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 215 48.74

More positions owned by Whittier Trust

Nvidia Corporation common (NVDA)
Microsoft Corp common (MSFT)
Apple common (AAPL)
Alphabet common (GOOG)
Amazon common (AMZN)
Ishares Tr common (IVV)
Spdr S&p 500 Etf Tr common (SPY)
Broadcom common (AVGO)
Jpmorgan Chase & Co. common (JPM)
Meta Platforms common (META)
Visa common (V)
Ishares Tr common (IJH)
Eli Lilly & Co common (LLY)
Berkshire Hathaway Inc Del common (BRK.B)
Servicenow common (NOW)

View all positions for Whittier Trust

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics